Literature DB >> 15352039

Expression of tumor necrosis factor receptor-associated factor 1 in nasopharyngeal carcinoma: possible upregulation by Epstein-Barr virus latent membrane protein 1.

Gabriele Siegler1, Birgit Meyer, Chris Dawson, Elena Brachtel, Jochen Lennerz, Claudia Koch, Elisabeth Kremmer, Edith Niedobitek, Roberta Gonnella, Ben Z Pilch, Lawrence S Young, Gerald Niedobitek.   

Abstract

EBV infection is associated with virtually all cases of undifferentiated NPC, and the EBV-encoded LMP1 is expressed in a proportion of cases. LMP1 has transforming functions similar to members of the TNF receptor family and activates intracellular signaling cascades through interaction with TRAFs. In B cells, expression of TRAF1 is in turn upregulated by LMP1. LMP1 signaling in epithelial cells may be affected by the presence or absence of TRAF1. By immunohistochemistry, we detected TRAF1 expression in 17 of 42 (40%) EBV+ undifferentiated NPCs. All 7 LMP1+ NPC biopsies were also TRAF1+. Using an RNAse protection assay, high-level TRAF1 expression was detected in an LMP1-expressing NPC-derived cell line (C15) and expression was weaker in 2 LMP1- cell lines (C17, C19). Finally, LMP1 upregulated TRAF1 expression in an EBV- keratinocyte cell line. Our results demonstrate that TRAF1 is expressed in NPC tumor cells in vivo and suggest that TRAF1 expression may be upregulated by LMP1 in NPC. An antiapoptotic function has been proposed for TRAF1, and this may be relevant for the pathogenesis of NPC. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15352039     DOI: 10.1002/ijc.20367

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Epstein-Barr virus latent membrane protein 1 modulates distinctive NF- kappaB pathways through C-terminus-activating region 1 to regulate epidermal growth factor receptor expression.

Authors:  Che-Pei Kung; Nancy Raab-Traub
Journal:  J Virol       Date:  2010-04-21       Impact factor: 5.103

2.  Tumour necrosis factor alpha 308 G/A is a risk marker for the progression from high-grade lesions to invasive cervical cancer.

Authors:  Hugo Sousa; Sara Oliveira; Alexandra M Santos; Raquel Catarino; José Moutinho; Rui Medeiros
Journal:  Tumour Biol       Date:  2013-11-07

3.  TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.

Authors:  Hannah Greenfeld; Kaoru Takasaki; Michael J Walsh; Ina Ersing; Katharina Bernhardt; Yijie Ma; Bishi Fu; Camille W Ashbaugh; Jackson Cabo; Sarah B Mollo; Hufeng Zhou; Shitao Li; Benjamin E Gewurz
Journal:  PLoS Pathog       Date:  2015-05-21       Impact factor: 6.823

4.  c-Myc and EBV-LMP1: two opposing regulators of the HLA class I antigen presentation machinery in epithelial cells.

Authors:  C S Tudor; C W Dawson; J Eckhardt; G Niedobitek; A C Büttner; B Seliger; A Hartmann; M Buettner
Journal:  Br J Cancer       Date:  2012-05-15       Impact factor: 7.640

Review 5.  Genetic Alterations of TRAF Proteins in Human Cancers.

Authors:  Sining Zhu; Juan Jin; Samantha Gokhale; Angeli M Lu; Haiyan Shan; Jianjun Feng; Ping Xie
Journal:  Front Immunol       Date:  2018-09-20       Impact factor: 7.561

6.  Regulation of Epstein-Barr Virus Life Cycle and Cell Proliferation by Histone H3K27 Methyltransferase EZH2 in Akata Cells.

Authors:  Takaya Ichikawa; Yusuke Okuno; Yoshitaka Sato; Fumi Goshima; Hironori Yoshiyama; Teru Kanda; Hiroshi Kimura; Takayuki Murata
Journal:  mSphere       Date:  2018-11-28       Impact factor: 4.389

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.